KathleenMaryBuchheitMD

PubMed

• TCF1-LEF1 co-expression identifies a multipotent progenitor cell (T2-MPP) across human allergic diseases.
  Radomir Kratchmarov, Sarah Djeddi, Garrett Dunlap, Wenqin He, Xiaojiong Jia, Caitlin M Burk, Tessa Ryan, Alanna McGill, Jessica R Allegretti, Raghu P Kataru, Babak J M...> ;Nature Immunology. 2024 Apr 8
• Utilization of protocols to lower daily aspirin dose prior to surgical procedures for patients with aspirin-exacerbated respiratory disease.
  Rose C Corcoran, Laura B Bailey, Alyson N Brown, Jillian C Bensko, Kathleen M Buchheit, Tanya M Laidlaw> ;The Journal of Allergy and Clinical Immunology. in Practice. 2024 Mar 18
• Efficacy of various dosing frequencies of dupilumab in patients with aspirin-exacerbated respiratory disease.
  Alyson N Brown, Tanya M Laidlaw, Kathleen M Buchheit, Jillian C Bensko, Rose C Corcoran, Laura B Bailey> ;The Journal of Allergy and Clinical Immunology. in Practice. 2024 Mar 12
• Consequences of NSAID allergy on pain control options for patients with aspirin-exacerbated respiratory disease.
  Laura B Bailey, Alyson N Brown, Rose C Corcoran, Jillian C Bensko, Kathleen M Buchheit, Tanya M Laidlaw> ;The Journal of Allergy and Clinical Immunology. in Practice. 2024 Feb 28
• A nasal cell atlas reveals heterogeneity of tuft cells and their role in directing olfactory stem cell proliferation.
  Ualiyeva, S., Lemire, E., Wong, C., Perniss, A., Boyd, A., Avilés, E., Minichetti, D., Maxfield, A., Roditi, R., Matsumoto, I., Wang, X., Deng, W., Barrett, N., Buchhe...> ;Science Immunology. 2024 Feb 2
• Absolute eosinophil counts in aspirin-exacerbated respiratory disease are distinctly elevated and correlate inversely with respiratory function.
  Omilabu, V., Bailey, L., Supron, A., Buchheit, K., Laidlaw, T.> ;The Journal of Allergy and Clinical Immunology. in Practice. 2024 Jan 27
• 1 citations
  Validation of a questionnaire assessing smell loss in an international aspirin-exacerbated respiratory disease population.
  Bensko, J. C., Marie Lundberg, Rie Maurer, Raffi Tchekmedyian, Jyotsna Mullur, Jillian C Bensko, Kathleen M Buchheit, Tanya M Laidlaw> ;Allergy and Asthma Proceedings. 2024 Jan 1
• Nasal polyp antibody-secreting cells display proliferation signature in aspirin-exacerbated respiratory disease.
  Aaqib Sohail, Jonathan Hacker, Tessa Ryan, Alanna McGill, Regan Bergmark, Neil Bhattacharyya, Stella E Lee, Alice Maxfield, Rachel Roditi, Amélie M Julé, Alec Griffith...> ;The Journal of Allergy and Clinical Immunology. 2024 Feb 1
• 1 citations
  Increased epithelial mTORC1 activity in chronic rhinosinusitis with nasal polyps.
  George X Huang, Nils R Hallen, Minkyu Lee, Kelly Zheng, Xin Wang, Michael V Mandanas, Sarah Djeddi, Daniela Fernandez, Jonathan Hacker, Tessa Ryan, Regan W Bergmark, N...> ;Biorxiv. 2023 Oct 17
• Progestogen Hypersensitivity.
  Sergio E Chiarella, Kathleen M Buchheit, Dinah Foer> ;The Journal of Allergy and Clinical Immunology. in Practice. 2023 Dec 1
• Local cytokine levels associate with SNOT-22 and UPSIT scores in chronic rhinosinusitis.
  Sophie E Yu, Simon Chiang, Tolani F Olonisakin, John A Moore, Regan W Bergmark, Alice Z Maxfield, Rachel E Roditi, Kathleen M Buchheit, Marie Lundberg, Margaret B Mitc...> ;International Forum of Allergy & Rhinology. 2024 Jan 1
• 5 citations
  Eosinophils and tissue remodeling: Relevance to airway disease.
  Salman Siddiqui, Claus Bachert, Leif Bjermer, Kathleen M Buchheit, Mario Castro, Yimin Qin, Hitasha Rupani, Hironori Sagara, Peter Howarth, Camille Taillé> ;The Journal of Allergy and Clinical Immunology. 2023 Oct 1
• Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth.
  Regan W Bergmark, Rachel E Roditi, Kathleen M Buchheit, Supron, A.> ;Annals of Allergy, Asthma & Immunology. 2023 Sep 1
• Not just snot: Local inflammatory profiles in patients with aspirin-exacerbated respiratory disease differ from patients with aspirin-tolerant chronic rhinosinusitis.
  Simon Chiang, Sophie E Yu, Tejas S Athni, Regan W Bergmark, Alice Z Maxfield, Rachel E Roditi, Kathleen M Buchheit, Marie Lundberg, Margaret B Mitchell, Stella E Lee> ;International Forum of Allergy & Rhinology. 2024 Jan 1
• Co-treatment of non-steroidal anti-inflammatory drug-exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization.
  Kathleen M Buchheit, Jonathan Hacker, Rie Maurer, Alanna McGill, Tessa Ryan, Tanya M Laidlaw, Bensko, J. C., Jillian C Bensko> ;Clinical and Experimental Allergy. 2023 Sep 1
• 2 citations
  Aspirin-exacerbated respiratory disease: Updates in the era of biologics.
  Jyostna Mullur, Kathleen M Buchheit> ;Annals of Allergy, Asthma & Immunology. 2023 Sep 1
• 2 citations
  Trial of thromboxane receptor inhibition with ifetroban: TP receptors regulate eicosanoid homeostasis in aspirin-exacerbated respiratory disease.
  Tanya M Laidlaw, Kathleen M Buchheit, Katherine N Cahill, Jonathan Hacker, Laura Cho, Jing Cui, Chunli Feng, Chongjia C Chen, Meghan Le, Elliot Israel, Joshua A Boyce> ;The Journal of Allergy and Clinical Immunology. 2023 Sep 1
• 3 citations
  Endotyping Chronic Rhinosinusitis with Nasal Polyps: Understanding Inflammation Beyond Phenotypes.
  Chongjia C Chen, Kathleen M Buchheit> ;American Journal of Rhinology & Allergy. 2023 Mar 1
• 5 citations
  Type 2 inflammation drives an airway basal stem cell program through insulin receptor substrate signaling.
  Xin Wang, Nils R Hallen, Minkyu Lee, Sachin Samuchiwal, Qihua Ye, Kathleen M Buchheit, Alice Z Maxfield, Rachel E Roditi, Regan W Bergmark, Neil Bhattacharyya, Tessa R...> ;The Journal of Allergy and Clinical Immunology. 2023 Jun 1
• Two-step nonsteroidal anti-inflammatory drug challenges during pregnancy: A case series.
  Lily Li, Jillian Bensko, Carolyn H Baloh, Carolina Bibbo, Kathleen M Buchheit> ;The Journal of Allergy and Clinical Immunology. in Practice. 2023 Feb 1
• 35 citations
  Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era.
  Joaquim Mullol, Antoine Azar, Kathleen M Buchheit, Claire Hopkins, Jonathan A Bernstein> ;The Journal of Allergy and Clinical Immunology. in Practice. 2022 Jun 1
• 3 citations
  Loss of smell in patients with aspirin-exacerbated respiratory disease impacts mental health and quality of life.
  Raffi Tchekmedyian, Marie Lundberg, Kathleen M Buchheit, Rie Maurer, Deborah Gakpo, Jyotsna Mullur, Jillian C Bensko, Tanya M Laidlaw> ;Clinical and Experimental Allergy. 2022 Dec 1
• 7 citations
  Aspirin desensitization and biologics in aspirin-exacerbated respiratory disease: Efficacy, tolerability, and patient experience.
  Jyotsna Mullur, Camille M Steger, Deborah Gakpo, Jillian C Bensko, Rie Maurer, Tanya M Laidlaw, Kathleen M Buchheit> ;Annals of Allergy, Asthma & Immunology. 2022 May 1
• 12 citations
  Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease.
  Kathleen M Buchheit, Aaqib Sohail, Jonathan Hacker, Rie Maurer, Deborah Gakpo, Jillian C Bensko, Faith Taliaferro, Jose Ordovas-Montanes, Tanya M Laidlaw> ;The Journal of Allergy and Clinical Immunology. 2022 Aug 1
• Inhibiting the type 2 inflammatory pathway with dupilumab is associated with an increase in interleukin-4 and interleukin-18 production.
  Jymirah Morris, Tolani F Olonisakin, John A Moore, BaDoi Phan, Dana M Parker, Bliss A Uribe, Stephanie J Barel, Eve M R Bowers, Kathleen M Buchheit, Tanya M Laidlaw, S...> ;International Forum of Allergy & Rhinology. 2022 Oct 1
• Join now to see all

Journal Articles

• Allergic Inflammatory Memory in Human Respiratory Epithelial Progenitor Cells  
  Nora A Barrett, Tanya M Laidlaw, Daniel F Dwyer, Joshua A Boyce, Neil Bhattacharyya, Kathleen M Buchheit, Katherine N Cahill, Nature